The skin findings are erythematous necrotizing on the legs, which sounds like necrolytic migratory erythema. That's a classic sign of glucagonoma syndrome. Glucagonomas are usually pancreatic endocrine tumors arising from alpha cells. So the correct cell type here would be the alpha cells. The other options might include beta cells (insulinoma), delta cells (somatostatinoma), or others. The pain in the left upper quadrant could be due to the tumor's location. The elevated glucagon and the skin rash are key clues here. Let me check each option again to make sure. The question is about which cell type is responsible. So alpha cells produce glucagon. The other options would be incorrect because they produce different hormones. Got it.
**Core Concept**
This case describes **glucagonoma syndrome**, a paraneoplastic syndrome caused by a pancreatic neuroendocrine tumor secreting excessive glucagon. The key features are hyperglycemia, a necrotizing erythematous skin rash (necrolytic migratory erythema), and pancreatic tumor. Glucagon is produced by **alpha (α) cells** in the islets of Langerhans.
**Why the Correct Answer is Right**
The patient’s elevated glucagon levels, hyperglycemia, and necrolytic rash are hallmark findings of a glucagonoma. Glucagonomas arise from **pancreatic alpha cells**, which normally secrete glucagon to increase blood glucose. Excess glucagon promotes gluconeogenesis and glycogenolysis, worsening hyperglycemia. The skin lesions result from pyridoxine deficiency induced by glucagon excess. The tumor’s location in the pancreas aligns with alpha cell origin.
**Why Each Wrong Option is Incorrect**
**Option A:** Beta (β) cells secrete insulin; their tumors (insulinomas) cause hypoglycemia, not hyperglycemia.
**Option B:** Delta (δ) cells produce somatostatin, and somatostatinomas cause diabetes but lack the characteristic skin rash.
**Option C:** PP (F) cells secrete pancreatic polypeptide, and their tumors are rare and asymptomatic.
**Clinical Pearl / High-Yield Fact**
**Necrolytic migratory erythema** is a **pathognomonic** skin finding in glucagonoma syndrome. Remember the “4 Ds” of glucagonoma: **Diabetes mellitus**, **Diarrhea** (not present here), **Dermatosis**, and **Weight loss** (not explicitly mentioned but implied by tumor).
**Correct Answer: C. Alpha (α) cells**
Free Medical MCQs · NEET PG · USMLE · AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.